Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
40.17
+0.54 (1.36%)
At close: May 19, 2026, 4:00 PM EDT
39.00
-1.17 (-2.91%)
After-hours: May 19, 2026, 7:06 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $2.45 billion as of May 19, 2026. Its market cap has increased by 143.11% in one year.
Market Cap
2.45B
Enterprise Value
2.00B
1-Year Change
143.11%
Ranking
Category
Stock Price
$40.17
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $2.45B, an increase of 151.18%. That is a compound annual growth rate of 32.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 2.41B | 164.09% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 2.69B |
| Vera Therapeutics | 2.68B |
| Arcutis Biotherapeutics | 2.67B |
| Disc Medicine | 2.55B |
| IDEAYA Biosciences | 2.48B |
| Nanobiotix | 2.47B |
| Celldex Therapeutics | 2.46B |
| Ultragenyx Pharmaceutical | 2.45B |